发明名称 |
Crystalline (-)-6- chloro-4- cyclopropylethynyl- 4-trifluoromethyl- 3,4-dihydro-2(1h)-quinazolinone |
摘要 |
The potent reverse transcriptase inhibitor (-)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-2(1H)-quinazolinone is produced in solvate and crystalline form. These forms are designated Forms 1 and 2, and are characterized by x-ray powder diffraction and differential scanning calorimetry. Pharmaceutical compositions and methods are useful for the treatment of the human immunodeficiency virus (HIV). |
申请公布号 |
AU1735000(A) |
申请公布日期 |
2000.06.05 |
申请号 |
AU20000017350 |
申请日期 |
1999.11.18 |
申请人 |
DU PONT PHARMACEUTICALS COMPANY |
发明人 |
SHELLY R. RABEL;MONA PATEL;RODNEY LAWRENCE PARSONS JR. |
分类号 |
A61P31/18;C07D239/78;C07D239/80 |
主分类号 |
A61P31/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|